Claris Lifesciences soars on settling litigations and license pact for generic DIPRIVAN

20 Apr 2015 Evaluate

Claris Lifesciences is currently trading at Rs. 326.20, up by 17.20 points or 5.57% from its previous closing of Rs. 309.00 on the BSE.

The scrip opened at Rs. 334.00 and has touched a high and low of Rs. 334.00 and Rs. 314.80 respectively. So far 343968 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 358.00 on 13-Apr-2015 and a 52 week low of Rs. 141.25 on 02-Jun-2014.

Last one week high and low of the scrip stood at Rs. 358.00 and Rs. 304.00 respectively. The current market cap of the company is Rs. 1736.35 crore.

The promoters holding in the company stood at 60.99% while Institutions and Non-Institutions held 24.79% and 14.22% respectively.

Claris Lifesciences (Claris) has reached a settlement and license agreement, ending all pending litigation with Fresenius Kabi USA, Inc with reference to the alleged infringement of a patent relating to Propofol for Injection, 10 mg/ml, which is a generic version of DIPRIVAN.

Under the terms of the settlement and license agreement, Claris and Claris Lifesciences Inc (USA) has been granted approval to sell its generic version of Propofol for Injection beginning October 15, 2016, prior to the June 1, 2025 expiry of the patent that formed the basis of the litigation.  According to IMS health data as of June 2014, Propofol Injection had an annual market size of approximately US$ 251 million in the USA.

Claris manufactures and markets products across multiple delivery systems, markets, and therapeutic segments including anesthesia, blood products, anti-infectives, and plasma volume expanders. A significant majority of these products are generic drugs that are capable of being directly injected into the human body, which are predominantly used in the treatment of critical illnesses.

 

Peers
Company Name CMP
Redington 274.90
Adani Enterprises 2260.00
Amrapali Industries 15.72
Rashi Peripheral 329.00
PDS 355.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×